Canada· CA-DIN-02290979
HEPAGAM B
A hepatitis b immunoglobulin product containing hepatitis b immunoglobulin (human), registered in Canada by KI BIOPHARMA LLC. The same ATC class is registered in 12 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Hepatitis b immunoglobulin is registered in 12 of 19 countries.
Countries holding a registration under ATC J06BB04 (hepatitis b immunoglobulin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Hepatitis b immunoglobulin · ATC J06BB04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- HEPATITIS B IMMUNOGLOBULIN (HUMAN)
- Manufacturer
- KI BIOPHARMA LLC
- Country
- Canada (CA)
- ATC code
- J06BB04
- ATC class
- Hepatitis B immunoglobulin
- Defined daily dose
- 500 E, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hepatitis b immunoglobulin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomHepatect CP 100units/2ml solution for infusion vialsBiotest (UK) Ltd
- SwitzerlandHepatect CP, InfusionslösungBiotest (Schweiz) AG
- SpainHEPATECT 50 UI/ml SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- PolandGAMMA anty-HBs 200Synthaverse S.A.
- Japan乾燥抗ＨＢｓ人免疫グロブリン武田薬品工業
- FranceIMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB 100 UI/mL, solution injectable en seringue préremplie (IM)LFB-BIOMEDICAMENTS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1fc02d84-2dfa-4bf2-9481-4bdd04f839e3 GET /v1/drugs/1fc02d84-2dfa-4bf2-9481-4bdd04f839e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02290979",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS",
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J06BB04",
"schedule": [
"Schedule D"
],
"drug_code": "77637",
"strengths": [
"312 UNIT"
],
"ahfs_class": null,
"substances": [
"HEPATITIS B IMMUNOGLOBULIN (HUMAN)"
],
"product_categorization": null
}See everything about hepatitis b immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.